Jim Simons Karyopharm Therapeutics Inc. Transaction History

Renaissance Technologies LLC

$63.1 Billion
Q3 2024

A detailed history of Jim Simons (Renaissance Technologies LLC) transactions in Karyopharm Therapeutics Inc. stock. As of the latest transaction made, Renaissance Technologies LLC holds 1,241,407 shares of KPTI stock, worth $868,984. This represents 0.0% of its overall portfolio holdings.

Number of Shares

1,241,407

Previous 756,227 64.16%

Holding current value

$868,984

Previous $657,000 56.77%

% of portfolio

0.0%

Previous 0.0%

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	BUY	$0.7 - $1.06 $339,626 - $514,290	485,180 Added 64.16%	1,241,407 $1.03 Million
Q2 2024 Aug 09, 2024	SELL	$0.87 - $1.58 $130,998 - $237,905	-150,573 Reduced 16.6%	756,227 $657,000
Q1 2024 May 13, 2024	SELL	$0.72 - $1.66 $761,455 - $1.76 Million	-1,057,577 Reduced 53.84%	906,800 $1.37 Million
Q4 2023 Feb 13, 2024	BUY	$0.68 - $1.31 $839,104 - $1.62 Million	1,233,977 Added 168.95%	1,964,377 $1.7 Million
Q3 2023 Nov 14, 2023	BUY	$1.14 - $1.81 $71,820 - $114,030	63,000 Added 9.44%	730,400 $979,000
Q2 2023 Aug 11, 2023	SELL	$1.79 - $4.59 $122,257 - $313,497	-68,300 Reduced 9.28%	667,400 $1.2 Million
Q1 2023 May 12, 2023	BUY	$2.84 - $3.92 $1.55 Million - $2.14 Million	546,400 Added 288.64%	735,700 $2.86 Million
Q4 2022 Feb 13, 2023	SELL	$2.48 - $5.93 $295,120 - $705,670	-119,000 Reduced 38.6%	189,300 $644,000
Q3 2022 Nov 14, 2022	SELL	$4.08 - $5.82 $597,720 - $852,630	-146,500 Reduced 32.21%	308,300 $1.68 Million
Q2 2022 Aug 12, 2022	BUY	$4.15 - $8.37 $994,755 - $2.01 Million	239,700 Added 111.44%	454,800 $2.05 Million
Q1 2022 May 13, 2022	BUY	$5.91 - $14.38 $763,572 - $1.86 Million	129,200 Added 150.41%	215,100 $1.59 Million
Q4 2021 Feb 11, 2022	SELL	$5.21 - $8.61 $2.13 Million - $3.53 Million	-409,500 Reduced 82.66%	85,900 $552,000
Q3 2021 Nov 12, 2021	BUY	$4.45 - $10.63 $2.12 Million - $5.07 Million	476,928 Added 2581.9%	495,400 $2.88 Million
Q2 2021 Aug 13, 2021	BUY	$8.11 - $11.11 $149,807 - $205,223	18,472 New	18,472 $191,000
Q3 2020 Nov 13, 2020	SELL	$14.14 - $19.71 $2.57 Million - $3.58 Million	-181,800 Closed	0 $0
Q2 2020 Aug 13, 2020	SELL	$16.6 - $25.25 $5.85 Million - $8.89 Million	-352,200 Reduced 65.96%	181,800 $3.44 Million
Q1 2020 May 14, 2020	BUY	$14.38 - $27.72 $5.37 Million - $10.4 Million	373,500 Added 232.71%	534,000 $10.3 Million
Q4 2019 Feb 13, 2020	BUY	$9.23 - $19.67 $1.48 Million - $3.16 Million	160,500 New	160,500 $3.08 Million
Q3 2019 Nov 13, 2019	SELL	$5.66 - $11.85 $416,094 - $871,152	-73,515 Closed	0 $0
Q2 2019 Aug 12, 2019	SELL	$4.32 - $6.43 $3.65 Million - $5.44 Million	-845,285 Reduced 92.0%	73,515 $440,000
Q1 2019 May 14, 2019	BUY	$4.12 - $10.25 $2.03 Million - $5.05 Million	492,547 Added 115.55%	918,800 $5.37 Million
Q4 2018 Feb 13, 2019	BUY	$8.2 - $16.95 $3.5 Million - $7.22 Million	426,253 New	426,253 $3.99 Million

Others Institutions Holding KPTI

# of Institutions

Shares Held

57.6M

Call Options Held

258K

Put Options Held

81.2K

View Full List

About Karyopharm Therapeutics Inc.

Ticker KPTI
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 79,806,600
Market Cap $55.9M
Description
Karyopharm Therapeutics Inc., a commercial-stage pharmaceutical company, discovers, develops, and commercializes drugs directed against nuclear export for the treatment of cancer and other diseases. The company discovers, develops, and commercializes novel and Selective Inhibitor of Nuclear Export (SINE) compounds function by binding with and in...

More about KPTI

Track Jim Simons's Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Renaissance Technologies LLC, based on Form 13F filings with the SEC.

News

Stay updated on Renaissance Technologies LLC and Jim Simons with notifications on news.

Account